Table 1.
Compound | Number of Concentrations | Mechanism of Action (MoA) | Replicates | Number of Images |
---|---|---|---|---|
Cytochalasin B | 2 | Actin disruption | 3 | 24 |
Cytochalasin D | 1 | Actin disruption | 3 | 12 |
Latrunculin B | 2 | Actin disruption | 3 | 24 |
AZ-A | 6 | Aurora kinase inhibition | 3 | 72 |
AZ258 | 3 | Aurora kinase inhibition | 3 | 36 |
AZ841 | 3 | Aurora kinase inhibition | 3 | 36 |
Mevinolin/lovastatin | 3 | Cholesterol lowering | 3 | 36 |
Simvastatin | 3 | Cholesterol lowering | 3 | 36 |
Chlorambucil | 1 | DNA damage | 3 | 12 |
Cisplatin | 1 | DNA damage | 3 | 12 |
Etoposide | 3 | DNA damage | 3 | 36 |
Mitomycin C | 4 | DNA damage | 3 | 48 |
Camptothecin | 3 | DNA replication | 3 | 36 |
Floxuridine | 2 | DNA replication | 3 | 24 |
Methotrexate | 1 | DNA replication | 3 | 12 |
Mitoxantrone | 2 | DNA replication | 3 | 24 |
AZ-C | 7 | Eg5 inhibition | 3 | 84 |
AZ138 | 5 | Eg5 inhibition | 3 | 60 |
AZ-J | 3 | Epithelial | 3 | 36 |
AZ-U | 3 | Epithelial | 3 | 36 |
PP-2 | 2 | Epithelial | 2 | 16 |
Alsterpaullone | 2 | Kinase inhibition | 2 | 16 |
Bryostatin | 1 | Kinase inhibition | 2 | 8 |
PD-169316 | 2 | Kinase inhibition | 2 | 16 |
Colchicine | 1 | Microtubule destabilization | 3 | 12 |
Demecolcine | 4 | Microtubule destabilization | 3 | 48 |
Nocodazole | 2 | Microtubule destabilization | 3 | 24 |
Vincristine | 7 | Microtubule destabilization | 3 | 84 |
Docetaxel | 3 | Microtubule stabilization | 3 | 36 |
Epothilone B | 3 | Microtubule stabilization | 3 | 36 |
Taxol | 3 | Microtubule stabilization | 3 | 36 |
ALLN | 2 | Protein degradation | 3 | 24 |
lactacystin | 1 | Protein degradation | 3 | 12 |
MG-132 | 2 | Protein degradation | 3 | 24 |
Proteasome inhibitor I | 2 | Protein degradation | 3 | 24 |
Anisomycin | 2 | Protein synthesis | 3 | 24 |
Cyclohexamide | 3 | Protein synthesis | 3 | 36 |
Emetine | 3 | Protein synthesis | 3 | 36 |
The “Number of Images” column represents the number of images before augmentation (through cropping).